AI assistance is associated with a superior improvement in detecting clinically significant prostate cancer on MRI, a ...

Clairity Breast analyzes subtle patterns in screening mammograms linked to future breast cancer risk, generating a validated ...

The Interdisciplinary Genitourinary Cancer Forum 2025, held between June 19 – 21, 2025 held in St. Petersburg, Florida, United States, was host to the Prostate Cancer Session 7: Non-metastatic ...

Esther Ugwueke is a biomedical expert and PhD student at the University of Nebraska Medical Center, United States, where she studies and researches lung cancer using bioinformatics, artificial ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Triple-negative breast cancer (TNBC) is one of the most aggressive and difficult-to-treat forms of breast cancer. Unlike ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces that its next-generation PSMA-PET imaging 1 agent for prostate cancer, Gozellix® (kit for the preparation ...

The drug pipeline—the process through which a potential new drug gets discovered, tested, approved, and marketed—is a ...

WEDNESDAY, June 18, 2025 (HealthDay News) — An experimental AI tool can help speed detection of melanoma and other skin ...

Recent advances in electronics and optics have opened new possibilities for terahertz (THz) waves—an invisible type of light ...

Advanced imaging and other diagnostic tools are increasing the number of cancers found in earlier stages, giving patients better odds at survival. But, the good news doesn’t end there, according ...